Affordability is tied to quality Viveka Roychowdhury Aug 17, 2023 In a freewheeling conversation, Leena Menghaney, Regional Head, MSF Access Campaign explains to Viveka Roychowdhury how the Covid…
World Tuberculosis Day reminds us of major global burden: GlobalData EP News Bureau Mar 23, 2023 Over the past 10 years, 668 clinical trials for TB treatments have been initiated, nearly 30 per cent of which have begun since…
Trial reveals BPaL regimen for highly drug-resistant TB is effective even with reduced dose of… EP News Bureau Jul 15, 2021 This regimen reduces the treatment time for highly drug-resistant forms of TB from 18 months or longer to a six-month duration
MSF and TB activists protest at 50th Union World Conference on Lung Health EP News Bureau Oct 31, 2019 The protesters urged pharma corporations to make improved drug-resistant TB (DR-TB) treatment affordable and available for…
TB Alliance and Macleods partners for new therapy for highly drug-resistant TB EP News Bureau Oct 29, 2019 Non-profit product development partnership and generic manufacturer agree to produce new TB drug for countries with high incidence…